Accumulating data demonstrated that the circulating levels of VEGF were higher in diabetic patients when compared to the healthy control individuals, with a noticeable positive correlation of plasma VEGF levels with diabetic microvascular complications; diabetic nephropathy, retinopathy and peripheral neuropathy [48–50]. This evidence concerns the gene VEGFA and diabetes mellitus.